Kanagawa, Japan

Takaaki Fukami

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takaaki Fukami. Retrieved from https://idiyas.com/inventor/takaaki-fukami

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takaaki Fukami: Innovator in Pharmaceutical Chemistry

Introduction

Takaaki Fukami is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of HSP90 inhibitors. His work has implications for various therapeutic applications, showcasing his expertise and dedication to innovation.

Latest Patents

Takaaki Fukami holds 1 patent related to HSP90 inhibitors. The patent details compounds represented by a specific formula, along with pharmaceutically acceptable salts and pharmaceutical compositions that include these compounds. This invention highlights his commitment to advancing medical science and improving treatment options.

Career Highlights

Fukami is associated with Chugai Pharmaceutical Co., Ltd., where he has been instrumental in research and development efforts. His work at the company reflects a strong focus on innovative solutions in the pharmaceutical industry. His contributions have been recognized within the scientific community, further establishing his reputation as a leading inventor.

Collaborations

Throughout his career, Takaaki Fukami has collaborated with esteemed colleagues, including Takuo Tsukuda and Ken-Ichi Kawasaki. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking discoveries.

Conclusion

Takaaki Fukami's contributions to pharmaceutical chemistry, particularly through his patent on HSP90 inhibitors, demonstrate his innovative spirit and commitment to advancing healthcare solutions. His work continues to inspire future research and development in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…